EXCHANGE AGREEMENTExchange Agreement • May 16th, 2022 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • New York
This Exchange Agreement (this “Agreement”), dated as of May 9, 2022, is made by and between RetinalGenix Technologies Inc., a Delaware corporation (the “Company”), and Sanovas Ophthalmology, LLC as the holder of the Debt (as defined below) (the “Holder”).
OPTION EXCHANGE AGREEMENTOption Exchange Agreement • August 5th, 2021 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • New Jersey
This OPTION EXCHANGE AGREEMENT, dated as of October 8, 2019 (this “Agreement”), by and between RETINALGENIX TECHNOLOGIES, INC., a Delaware corporation having an address of P.O. 2129 San Rafael, California 94912 (“RG”) and DIOPSYS, INC., a Delaware corporation having an address at 16 Chapin Road, Suite 911-912, Pine Brook, New Jersey 07058 (“DIOPSYS”). For purposes of this Agreement RG and DIOPSYS are sometimes collectively referred to as the “Parties” and individually as a “Party.”
RETINALGENIX TECHNOLOGIES INC. 2017 EQUITY INCENTIVE PLAN [as of December 1, 2017]2017 Equity Incentive Plan • August 5th, 2021 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • Delaware
Consulting AgreementConsulting Agreement • December 4th, 2023 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • Delaware
This Agreement, dated December 1, 2023, is made between RetinalGenix Technologies, Inc., a Delaware corporation (“Client”) with a principal place of business at 1450 North McDowell Boulevard, Suite 150 Petaluma, CA and TRENDZ Network, LLC (“Consultant”), with a place of business at 13460A Watsonville Road, Morgan Hill, CA.
EXCHANGE AGREEMENTExchange Agreement • July 7th, 2022 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • Delaware
THIS EXCHANGE AGREEMENT (the “Agreement”) is dated as of July 5, 2022, by and among RETINALGENIX TECHNOLOGIES, INC., a Delaware corporation (“Parent”), DNA/GPS INC., a Delaware corporation (“Company”), and LAWRENCE PERICH, an individual (the “Stockholder”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
EXCHANGE AGREEMENTExchange Agreement • December 30th, 2021 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • New York
This Exchange Agreement (this “Agreement”), dated as of December 27, 2021, is made by and between RetinalGenix Technologies Inc., a Delaware corporation (the “Company”), and Sanovas Ophthalmology, LLC as the holder of the Exchange Securities (as defined below) (the “Holder”).
SUBLICENSE AGREEMENTSublicense Agreement • June 28th, 2021 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • California
THIS AGREEMENT is entered into this 24th day of June, 2021 (the “Effective Date”), by and between Sanovas Ophthalmology LLC, a Nevada limited liability company having its principal office at 9120 Double Diamond Parkway, Reno NC 89521 (“Licensee”), and Retinalgenix Technologies, Inc., a corporation having its principal 1450 N. McDowell Blvd, Petaluma, CA 94954 (“Sublicensee”) (each of Licensee and Sublicensee a “Party,” and together, the “Parties”).
PRE-FUNDED COMMON STOCK PURCHASE WARRANT RETINALGENIX TECHNOLOGIES, INC.Pre-Funded Warrant Agreement • December 30th, 2021 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Sanovas Ophthalmology, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from RetinalGenix Technologies Inc., a Delaware corporation (the “Company”), up to 28,014,540 shares (as subject to adjustment hereunder, the “Warrant Shares” and together with the Warrant, the “Securities”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
AMENDED AND RESTATED MASTER SERVICES AGREEMENTMaster Services Agreement • August 5th, 2021 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • New Jersey
THIS AMENDED AND RESTATED AGREEMENT (this “Agreement”), is made and entered into on this 24th day of June 2021, retroactive to the 13th day of December 2019, by and between ADM Tronics Unlimited, Inc., with offices located at 224S Pegasus Ave., Northvale, NJ 07647 (“ADMT”) and RetinalGenix Technologies Inc., with offices located at 1450 North McDowell Blvd., Suite 150, Petaluma, CA 94954 (the “Client”).
